Cesarean Section ComplicationsNCT04752904
Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery
A study testing ClearSight System in people with Cesarean Section Complications and Hypotension, run by Seoul National University Hospital at 1 site in South Korea.
Trial summary
Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial Read more about this study
- Who is it for?
- Ages 19 years and older, women only
- Conditions the study is for
- Cesarean Section Complications, Hypotension
- What is being tested?
- ClearSight System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 154 participants
- Where
- 1 siteSouth Korea
- Study dates
- 27 Apr 2021to 21 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult mothers who are pregnant with single fetuses over 35 weeks gestational age undergoing planned cesarean delivery under spinal anesthesia
Who cannot join
- Multiple fetal pregnancy
- Preexisting hypertension or pregnancy-induced hypertension
- Underlying heart disease
- Underlying cerebrovascular disease
- Known fetal anomaly
- Contraindicated in spinal anesthesia
Show all 10Show fewer
- Any sign of onset of labor
- Body weight <45 kg or body weight> 90 kg
- Height <145cm or height> 180cm
- All other cases in which researchers determine to be inappropriate for this clinical trial
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Noninvasive Continuous Blood Pressure Monitoring for Preventing Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Trial
Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial
Read the detailed description
The aim of this study was to find out whether the incidence of hypotension during surgery can be reduced in the case of non-invasive, continuous blood pressure monitoring using the ClearSight System in patients undergoing cesarean section under spinal anesthesia, compared to the case of using conventional noninvasive blood pressure monitoring
- Conditions
- Cesarean Section Complications, Hypotension
- Being tested
- ClearSight System
- Keywords
- noninvasive continuous blood pressure monitoring
- Medical subject headings
- Hypotension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ClearSight SystemDevice
Non-invasive, continuous blood pressure is monitored using ClearSight Sytem
| Study group | Role | What they receive |
|---|---|---|
| ClearSight group | Experimental | Non-invasive, continuous blood pressure is monitored using ClearSight Sytem, with a finger cuff around the middle finger, and the anesthesiologist manages blood pressure based on this. Receives: Device: ClearSight System |
| Control group | No intervention | The blood pressure is measured at 1-minute intervals by non-invasive blood pressure monitor using the arm cuff, and the anesthesiologist in charge manages the blood pressure based on the measured blood pressure. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of hypotension by individualized methods
Hypotension was defined as: SBP<80% of baseline SBP
Measured: From spinal anesthesia to delivery
Secondary outcomes (20)
Incidence of hypotension by standard methods
Hypotension was defined as MBP<65mmHg
Measured: From spinal anesthesia to delivery
Time-weighted average SBP<80% of baseline SBP
Time-weighted average SBP<80% of baseline SBP
Measured: From spinal anesthesia to delivery
Time-weighted average MAP <65mmHg
Time-weighted average MAP <65mmHg
Measured: From spinal anesthesia to delivery
Incidence of intraoperative severe hypotension
Defined as: SBP < 70% of baseline SBP
Measured: From spinal anesthesia to delivery
Incidence of intraoperative symptomatic hypotension
Defined as: hypotension plus nausea and/or vomiting and/or dizziness and/or breathlessness
Measured: From spinal anesthesia to delivery
Incidence of nausea, vomiting, dizziness, breathlessness
Incidence of nausea, vomiting, dizziness, breathlessness
Measured: From spinal anesthesia to delivery
Incidence of intraoperative Hypertension
SBP> 120% of baseline SBP
Measured: From spinal anesthesia to delivery
Maximum, Minimum recorded SBP, DBP, MBP
Maximum, Minimum recorded SBP, DBP, MBP
Measured: From spinal anesthesia to delivery
Cumulative duration of hypotension
Cumulative duration of hypotension
Measured: From spinal anesthesia to delivery
Number of hypotensive episodes
Number of hypotensive episodes
Measured: From spinal anesthesia to delivery
Onset time of hypotension
Onset time of hypotension
Measured: From spinal anesthesia to delivery
Cumulative consumptions of vasopressors
Cumulative consumptions of vasopressors
Measured: From spinal anesthesia to delivery
Incidence of bradycardia
HR (heart rate) <50 bpm
Measured: From spinal anesthesia to delivery
Incidence of atropine use
Incidence of atropine use
Measured: From spinal anesthesia to delivery
Minimum heart rate
Minimum heart rate
Measured: From spinal anesthesia to delivery
Cardiac output, stroke volume
only in ClearSight System group
Measured: From spinal anesthesia to delivery
The analysis of the differences between the test method (ClearSight) and reference method
Bland-Altman analysis
Measured: From spinal anesthesia to delivery
Apgar Score
1 minute, 5 minutes
Measured: at 1 minute after delivery and 5 minutes after delivery
Umbilical arterial blood
Arterial blood gas analysis results
Measured: within 10 minutes after delivery
Umbilical arterial pH
<7.2
Measured: within 10 minutes after delivery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2021
- Study start27 Apr 2021
- Primary completion26 Oct 2022
- Study completion21 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (13)Papers the sponsor has linked to this study.
- Other trials for Cesarean Section ComplicationsStudies of the same condition, open and under way.
- More trials run by Seoul National University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized double blind controlled trial
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 154 participants (actual)
Sponsor and investigators
- Lead sponsor
- Seoul National University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sun-Kyung Park, Seoul National University Hospital
- Investigators
- Sun-Kyung Park, M.D, Principal investigator, Seoul National University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04752904
- Sponsor's protocol ID
- 2010-093-1165
- Status last verified
- Dec 2022
- First submitted
- 5 Feb 2021
- Last updated
- 28 Dec 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Wei C, Qian J, Zhang Y, Chang X, Hu H, Xiao F. Norepinephrine for the prevention of spinal-induced hypotension during caesarean delivery under combined spinal-epidural anaesthesia: Randomised, double-blind, dose-finding study. Eur J Anaesthesiol. 2020 Apr;37(4):309-315. doi: 10.1097/EJA.0000000000001152.
PubMed 31977628Hasanin AM, Amin SM, Agiza NA, Elsayed MK, Refaat S, Hussein HA, Rouk TI, Alrahmany M, Elsayad ME, Elshafaei KA, Refaie A. Norepinephrine Infusion for Preventing Postspinal Anesthesia Hypotension during Cesarean Delivery: A Randomized Dose-finding Trial. Anesthesiology. 2019 Jan;130(1):55-62. doi: 10.1097/ALN.0000000000002483.
PubMed 30335625Fitzgerald JP, Fedoruk KA, Jadin SM, Carvalho B, Halpern SH. Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials. Anaesthesia. 2020 Jan;75(1):109-121. doi: 10.1111/anae.14841. Epub 2019 Sep 18.
PubMed 31531852Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, Palanisamy A, Sia ATH, Van de Velde M, Vercueil A; Consensus Statement Collaborators. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018 Jan;73(1):71-92. doi: 10.1111/anae.14080. Epub 2017 Nov 1. No abstract available.
PubMed 29090733Juri T, Suehiro K, Kimura A, Mukai A, Tanaka K, Yamada T, Mori T, Nishikawa K. Impact of non-invasive continuous blood pressure monitoring on maternal hypotension during cesarean delivery: a randomized-controlled study. J Anesth. 2018 Dec;32(6):822-830. doi: 10.1007/s00540-018-2560-2. Epub 2018 Sep 28.
PubMed 30267340Bartels K, Esper SA, Thiele RH. Blood Pressure Monitoring for the Anesthesiologist: A Practical Review. Anesth Analg. 2016 Jun;122(6):1866-79. doi: 10.1213/ANE.0000000000001340.
PubMed 27195632Rogge DE, Nicklas JY, Schon G, Grothe O, Haas SA, Reuter DA, Saugel B. Continuous Noninvasive Arterial Pressure Monitoring in Obese Patients During Bariatric Surgery: An Evaluation of the Vascular Unloading Technique (Clearsight system). Anesth Analg. 2019 Mar;128(3):477-483. doi: 10.1213/ANE.0000000000003943.
PubMed 30649073Noto A, Sanfilippo F, De Salvo G, Crimi C, Benedetto F, Watson X, Cecconi M, David A. Noninvasive continuous arterial pressure monitoring with Clearsight during awake carotid endarterectomy: A prospective observational study. Eur J Anaesthesiol. 2019 Feb;36(2):144-152. doi: 10.1097/EJA.0000000000000938.
PubMed 30562226Ngan Kee WD, Lee SWY, Ng FF, Lee A. Norepinephrine or phenylephrine during spinal anaesthesia for Caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome. Br J Anaesth. 2020 Oct;125(4):588-595. doi: 10.1016/j.bja.2020.05.057. Epub 2020 Jul 15.
PubMed 32682556Vos JJ, Poterman M, Mooyaart EA, Weening M, Struys MM, Scheeren TW, Kalmar AF. Comparison of continuous non-invasive finger arterial pressure monitoring with conventional intermittent automated arm arterial pressure measurement in patients under general anaesthesia. Br J Anaesth. 2014 Jul;113(1):67-74. doi: 10.1093/bja/aeu091. Epub 2014 Apr 15.
PubMed 24740992Lawicka M, Malek A, Antczak D, Wajlonis A, Owczuk R. Non-invasive haemodynamic measurements with Nexfin predict the risk of hypotension following spinal anaesthesia. Anaesthesiol Intensive Ther. 2015;47(4):303-8. doi: 10.5603/AIT.2015.0048.
PubMed 26401736Chen G, Chung E, Meng L, Alexander B, Vu T, Rinehart J, Cannesson M. Impact of non invasive and beat-to-beat arterial pressure monitoring on intraoperative hemodynamic management. J Clin Monit Comput. 2012 Apr;26(2):133-40. doi: 10.1007/s10877-012-9344-2. Epub 2012 Mar 1.
PubMed 22382920Juri T, Suehiro K, Kimura A, Mukai A, Tanaka K, Yamada T, Mori T, Nishikawa K. Impact of continuous non-invasive blood pressure monitoring on hemodynamic fluctuation during general anesthesia: a randomized controlled study. J Clin Monit Comput. 2018 Dec;32(6):1005-1013. doi: 10.1007/s10877-018-0125-4. Epub 2018 Mar 6.
PubMed 29511971
Study at a glance
From the registry record, last updated by the sponsor on 28 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Noninvasive Continuous Blood Pressure Monitoring for Preventing Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT04752904
- Acronym / sponsor ID
- 2010-093-1165
- Conditions
- Cesarean Section Complications, Hypotension
- Keywords
- noninvasive continuous blood pressure monitoring
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 154 participants (actual)
- Lead sponsor
- Seoul National University HospitalUniversity, hospital or other
- Study start
- 27 Apr 2021 (actual)
- Primary completion
- 26 Oct 2022 (actual)
- Study completion
- 21 Dec 2022 (actual)
- First posted
- 12 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial
Detailed description
The aim of this study was to find out whether the incidence of hypotension during surgery can be reduced in the case of non-invasive, continuous blood pressure monitoring using the ClearSight System in patients undergoing cesarean section under spinal anesthesia, compared to the case of using conventional noninvasive blood pressure monitoring
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- randomized double blind controlled trial
| Arm | Type | Receives |
|---|---|---|
| ClearSight group | Experimental | Device: ClearSight SystemNon-invasive, continuous blood pressure is monitored using ClearSight Sytem, with a finger cuff around the middle finger, and the anesthesiologist manages blood pressure based on this. |
| Control group | No intervention | –The blood pressure is measured at 1-minute intervals by non-invasive blood pressure monitor using the arm cuff, and the anesthesiologist in charge manages the blood pressure based on the measured blood pressure. |
Who may qualify
- Ages
- 19 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Adult mothers who are pregnant with single fetuses over 35 weeks gestational age undergoing planned cesarean delivery under spinal anesthesia
Key exclusion criteria (10 listed)
- Multiple fetal pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ClearSight SystemNon-invasive, continuous blood pressure is monitored using ClearSight Sytem | Device | ClearSight group |
Primary outcome
Incidence of hypotension by individualized methods
Time frame: From spinal anesthesia to delivery
Hypotension was defined as: SBP<80% of baseline SBP
20 secondary outcomes
Incidence of hypotension by standard methods
Time frame: From spinal anesthesia to delivery
Time-weighted average SBP<80% of baseline SBP
Time frame: From spinal anesthesia to delivery
Time-weighted average MAP <65mmHg
Time frame: From spinal anesthesia to delivery
Incidence of intraoperative severe hypotension
Time frame: From spinal anesthesia to delivery
Incidence of intraoperative symptomatic hypotension
Time frame: From spinal anesthesia to delivery
Incidence of nausea, vomiting, dizziness, breathlessness
Time frame: From spinal anesthesia to delivery
Incidence of intraoperative Hypertension
Time frame: From spinal anesthesia to delivery
Maximum, Minimum recorded SBP, DBP, MBP
Time frame: From spinal anesthesia to delivery
Cumulative duration of hypotension
Time frame: From spinal anesthesia to delivery
Number of hypotensive episodes
Time frame: From spinal anesthesia to delivery
Onset time of hypotension
Time frame: From spinal anesthesia to delivery
Cumulative consumptions of vasopressors
Time frame: From spinal anesthesia to delivery
Incidence of bradycardia
Time frame: From spinal anesthesia to delivery
Incidence of atropine use
Time frame: From spinal anesthesia to delivery
Minimum heart rate
Time frame: From spinal anesthesia to delivery
Cardiac output, stroke volume
Time frame: From spinal anesthesia to delivery
The analysis of the differences between the test method (ClearSight) and reference method
Time frame: From spinal anesthesia to delivery
Apgar Score
Time frame: at 1 minute after delivery and 5 minutes after delivery
Umbilical arterial blood
Time frame: within 10 minutes after delivery
Umbilical arterial pH
Time frame: within 10 minutes after delivery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Dec 2022.
- Background: PubMed 31977628Wei C, Qian J, Zhang Y, Chang X, Hu H, Xiao F. Norepinephrine for the prevention of spinal-induced hypotension during caesarean delivery under combined spinal-epidural anaesthesia: Randomised, double-blind, dose-finding study. Eur J Anaesthesiol. 2020 Apr;37(4):309-315. doi: 10.1097/EJA.0000000000001152.
- Background: PubMed 30335625Hasanin AM, Amin SM, Agiza NA, Elsayed MK, Refaat S, Hussein HA, Rouk TI, Alrahmany M, Elsayad ME, Elshafaei KA, Refaie A. Norepinephrine Infusion for Preventing Postspinal Anesthesia Hypotension during Cesarean Delivery: A Randomized Dose-finding Trial. Anesthesiology. 2019 Jan;130(1):55-62. doi: 10.1097/ALN.0000000000002483.
- Background: PubMed 31531852Fitzgerald JP, Fedoruk KA, Jadin SM, Carvalho B, Halpern SH. Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials. Anaesthesia. 2020 Jan;75(1):109-121. doi: 10.1111/anae.14841. Epub 2019 Sep 18.
- Background: PubMed 29090733Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, Palanisamy A, Sia ATH, Van de Velde M, Vercueil A; Consensus Statement Collaborators. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018 Jan;73(1):71-92. doi: 10.1111/anae.14080. Epub 2017 Nov 1. No abstract available.
- Background: PubMed 30267340Juri T, Suehiro K, Kimura A, Mukai A, Tanaka K, Yamada T, Mori T, Nishikawa K. Impact of non-invasive continuous blood pressure monitoring on maternal hypotension during cesarean delivery: a randomized-controlled study. J Anesth. 2018 Dec;32(6):822-830. doi: 10.1007/s00540-018-2560-2. Epub 2018 Sep 28.
- Background: PubMed 27195632Bartels K, Esper SA, Thiele RH. Blood Pressure Monitoring for the Anesthesiologist: A Practical Review. Anesth Analg. 2016 Jun;122(6):1866-79. doi: 10.1213/ANE.0000000000001340.
- Background: PubMed 30649073Rogge DE, Nicklas JY, Schon G, Grothe O, Haas SA, Reuter DA, Saugel B. Continuous Noninvasive Arterial Pressure Monitoring in Obese Patients During Bariatric Surgery: An Evaluation of the Vascular Unloading Technique (Clearsight system). Anesth Analg. 2019 Mar;128(3):477-483. doi: 10.1213/ANE.0000000000003943.
- Background: PubMed 30562226Noto A, Sanfilippo F, De Salvo G, Crimi C, Benedetto F, Watson X, Cecconi M, David A. Noninvasive continuous arterial pressure monitoring with Clearsight during awake carotid endarterectomy: A prospective observational study. Eur J Anaesthesiol. 2019 Feb;36(2):144-152. doi: 10.1097/EJA.0000000000000938.
- Background: PubMed 32682556Ngan Kee WD, Lee SWY, Ng FF, Lee A. Norepinephrine or phenylephrine during spinal anaesthesia for Caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome. Br J Anaesth. 2020 Oct;125(4):588-595. doi: 10.1016/j.bja.2020.05.057. Epub 2020 Jul 15.
- Background: PubMed 24740992Vos JJ, Poterman M, Mooyaart EA, Weening M, Struys MM, Scheeren TW, Kalmar AF. Comparison of continuous non-invasive finger arterial pressure monitoring with conventional intermittent automated arm arterial pressure measurement in patients under general anaesthesia. Br J Anaesth. 2014 Jul;113(1):67-74. doi: 10.1093/bja/aeu091. Epub 2014 Apr 15.
- Background: PubMed 26401736Lawicka M, Malek A, Antczak D, Wajlonis A, Owczuk R. Non-invasive haemodynamic measurements with Nexfin predict the risk of hypotension following spinal anaesthesia. Anaesthesiol Intensive Ther. 2015;47(4):303-8. doi: 10.5603/AIT.2015.0048.
- Background: PubMed 22382920Chen G, Chung E, Meng L, Alexander B, Vu T, Rinehart J, Cannesson M. Impact of non invasive and beat-to-beat arterial pressure monitoring on intraoperative hemodynamic management. J Clin Monit Comput. 2012 Apr;26(2):133-40. doi: 10.1007/s10877-012-9344-2. Epub 2012 Mar 1.
- Individual participant dataSharing planned: No
Related trials for Cesarean Section Complications
Recruiting
Reducing Chronic Pain Following Cesarean Delivery
Chronic Pain, Cesarean Section Complications
Not yet recruiting
Empowered Relief for Severe Pain After Cesarean Delivery During the Inpatient Period
Severe Pain, Cesarean Section Complications
Recruiting
Platelet Rich Plasma for Uterine Scar
Cesarean Section Complications, Uterine Bleeding
Enrolling by invitation
Using Empowered Relief and Education To Help Postpartum Women Recover After Cesarean Delivery
Cesarean Section Complications, Postpartum Care
Recruiting
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
Cesarean Section Complications, Opioid Use
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sun-Kyung Park, M.D principal investigator
Seoul National University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ClearSight System in people with Cesarean Section Complications and Hypotension, run by Seoul National University Hospital at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of hypotension by individualized methods (time frame: From spinal anesthesia to delivery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04752904, which also lists 13 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2022.